| POTABA GLENWOOD INC.
478868 25 Nov 1981 | on 29 Jan 1983 | Class 005 Class 005 Pharmaceutical Products Medicinal preparation indicated for use in treating lupus erythematosus, dermatomyositis, sceroderma, acute rheumatic fever, dermatitis herpetiformis, pemphigus, lymphoblastomacutis, atopic dermatitis and eczema dermatitis, rheumatoid arthritis. | | | POTABA GLENWOOD LABORATORIES CANADA LTD.
301160 29 Nov 1966 | on 11 Aug 1967 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation. | | 
